James A. Karlowsky

2.0k total citations
40 papers, 1.4k citations indexed

About

James A. Karlowsky is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology. According to data from OpenAlex, James A. Karlowsky has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Medicine, 24 papers in Applied Microbiology and Biotechnology and 20 papers in Pharmacology. Recurrent topics in James A. Karlowsky's work include Antibiotic Resistance in Bacteria (32 papers), Antibiotic Use and Resistance (24 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). James A. Karlowsky is often cited by papers focused on Antibiotic Resistance in Bacteria (32 papers), Antibiotic Use and Resistance (24 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). James A. Karlowsky collaborates with scholars based in Canada, United States and Hong Kong. James A. Karlowsky's co-authors include Daniel F. Sahm, Christine Y. Turenne, Daryl J. Hoban, Amin Kabani, Stephen Sanche, Wright W. Nichols, Krystyna M. Kazmierczak, Boudewijn L. M. de Jonge, George G. Zhanel and Kimberly A. Nichol and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

James A. Karlowsky

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Karlowsky Canada 17 745 553 437 305 187 40 1.4k
E. Platsouka Greece 16 475 0.6× 256 0.5× 184 0.4× 160 0.5× 204 1.1× 33 906
Izabela Kern-Zdanowicz Poland 15 995 1.3× 319 0.6× 156 0.4× 103 0.3× 458 2.4× 31 1.4k
Sook Jin Jang South Korea 18 401 0.5× 295 0.5× 82 0.2× 93 0.3× 221 1.2× 59 962
Fátima Galán‐Sánchez Spain 15 260 0.3× 291 0.5× 128 0.3× 83 0.3× 95 0.5× 67 747
María García-Castillo Spain 22 842 1.1× 322 0.6× 314 0.7× 225 0.7× 274 1.5× 40 1.2k
Adam G. Stewart Australia 16 315 0.4× 232 0.4× 162 0.4× 115 0.4× 147 0.8× 77 868
A. Mena Spain 15 557 0.7× 169 0.3× 134 0.3× 67 0.2× 186 1.0× 23 1.0k
Christine Segonds France 21 433 0.6× 336 0.6× 120 0.3× 39 0.1× 423 2.3× 40 1.5k
Stefan Ziesing Germany 19 258 0.3× 361 0.7× 55 0.1× 77 0.3× 140 0.7× 46 1.0k
Yoon I. Kwak United States 20 801 1.1× 205 0.4× 152 0.3× 129 0.4× 315 1.7× 36 1.2k

Countries citing papers authored by James A. Karlowsky

Since Specialization
Citations

This map shows the geographic impact of James A. Karlowsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Karlowsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Karlowsky more than expected).

Fields of papers citing papers by James A. Karlowsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Karlowsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Karlowsky. The network helps show where James A. Karlowsky may publish in the future.

Co-authorship network of co-authors of James A. Karlowsky

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Karlowsky. A scholar is included among the top collaborators of James A. Karlowsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Karlowsky. James A. Karlowsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mataseje, Laura, Nicole Lerminiaux, Philippe Lagacé‐Wiens, et al.. (2025). Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007–23). Journal of Antimicrobial Chemotherapy. 80(Supplement_2). ii54–ii61. 1 indexed citations
2.
McCracken, Melissa, Andrew Walkty, Heather J. Adam, et al.. (2025). Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018–23). Journal of Antimicrobial Chemotherapy. 80(Supplement_2). ii62–ii71. 1 indexed citations
3.
Wise, Mark G., James A. Karlowsky, Naglaa Mohamed, et al.. (2024). Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022. Journal of Global Antimicrobial Resistance. 37. 168–175. 35 indexed citations
4.
Zhanel, George G., Courtney K. Lawrence, Sheryl Zelenitsky, et al.. (2024). Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination. Drugs. 84(10). 1219–1250. 11 indexed citations
5.
Karlowsky, James A., Sibylle Lob, Wei‐Ting Chen, et al.. (2023). In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020. International Journal of Antimicrobial Agents. 62(3). 106900–106900. 3 indexed citations
6.
7.
Wise, Mark G., James A. Karlowsky, Meredith Hackel, et al.. (2023). In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021. Journal of Global Antimicrobial Resistance. 35. 93–100. 4 indexed citations
8.
Karlowsky, James A., Sibylle Lob, Karri A. Bauer, et al.. (2023). Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates—SMART United States 2019–21. JAC-Antimicrobial Resistance. 6(1). dlad152–dlad152. 11 indexed citations
9.
10.
Wise, Mark G., James A. Karlowsky, Meredith Hackel, et al.. (2023). In Vitro Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014–2019. Microbial Drug Resistance. 29(8). 360–370. 21 indexed citations
11.
Karlowsky, James A., Sibylle Lob, Katherine Young, Mary Motyl, & Daniel F. Sahm. (2021). Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019. BMC Microbiology. 21(1). 74–74. 22 indexed citations
12.
Golden, Alyssa, Melanie Baxter, James A. Karlowsky, et al.. (2021). Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007–19. JAC-Antimicrobial Resistance. 4(1). dlab197–dlab197. 18 indexed citations
13.
14.
Adam, Heather J., Melanie Baxter, Ross Davidson, et al.. (2013). Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals. Journal of Antimicrobial Chemotherapy. 68(suppl 1). i31–i37. 42 indexed citations
15.
Bridger, Natalie, Andrew Walkty, Maryanne Crockett, et al.. (2012). Caulobacter Species as a Cause of Postneurosurgical Bacterial Meningitis in a Pediatric Patient. Canadian Journal of Infectious Diseases and Medical Microbiology. 23(1). e10–2. 6 indexed citations
16.
Zhanel, George G., Kimberly A. Nichol, Heather J. Adam, et al.. (2012). Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model. Journal of Antimicrobial Chemotherapy. 67(7). 1706–1711. 4 indexed citations
17.
Zhanel, George G., Tamiko Hisanaga, Nancy M. Laing, et al.. (2006). Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). International Journal of Antimicrobial Agents. 27(6). 468–475. 226 indexed citations
18.
Karlowsky, James A., Mark E. Jones, Clyde Thornsberry, et al.. (2001). Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. International Journal of Antimicrobial Agents. 18(2). 121–127. 72 indexed citations
19.
Turenne, Christine Y., Stephen Sanche, Daryl J. Hoban, James A. Karlowsky, & Amin Kabani. (1999). Rapid Identification of Fungi by Using the ITS2 Genetic Region and an Automated Fluorescent Capillary Electrophoresis System. Journal of Clinical Microbiology. 37(6). 1846–1851. 339 indexed citations
20.
Zhanel, George G., James A. Karlowsky, & Daryl J. Hoban. (1998). In Vitro Activities of Six Fluoroquinolones against Canadian Isolates of Vancomycin-sensitive and Vancomycin-resistant Enterococcus species. Diagnostic Microbiology and Infectious Disease. 31(2). 343–347. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Platsouka Breakdown of academic impact, for papers by Izabela Kern-Zdanowicz Breakdown of academic impact, for papers by Sook Jin Jang Breakdown of academic impact, for papers by Fátima Galán‐Sánchez Breakdown of academic impact, for papers by María García-Castillo Breakdown of academic impact, for papers by Adam G. Stewart Breakdown of academic impact, for papers by A. Mena Breakdown of academic impact, for papers by Christine Segonds Breakdown of academic impact, for papers by Stefan Ziesing Breakdown of academic impact, for papers by Yoon I. Kwak
Rankless by CCL
2026